F042 Advanced Dermoscopy
DESCRIPTION
Learn practical, advanced dermoscopy skills directly from leading international experts. This session is designed for dermatologists with a strong foundation in dermoscopy who want to elevate their ability to diagnose complex skin and nail diseases. Faculty will share real-world cases, expert tips, and new techniques, including UV dermoscopy, inflammoscopy, and advanced nail dermoscopy. Attendees will leave with practical insights and strategies they can immediately apply in clinical practice to improve diagnostic accuracy and confidence.
LEARNING OBJECTIVES
Detect advanced dermoscopic features associated with melanoma.
Describe dermoscopic patterns in inflammatory skin diseases.
Recognize and interpret key dermoscopic findings in facial and nail disorders.
SCHEDULE
3:30 PM
Advanced Dermoscopic Clues to Predict Invasive Melanomas
Konstantinos Liopyris, MD
3:50 PM
Dermoscopy for Diagnosing Inflammatory Conditions
Michelle B. Tarbox, MD, FAAD
4:10 PM
Dermoscopy for Non-Pigmented Nail Lesions
Luc Thomas, MD, PhD
4:30 PM
Advanced Facial Dermoscopy Including UV Clues
Cristian Navarrete-Dechent, MD, IFAAD
4:50 PM
Advanced Dermoscopy Cases
Jennifer A. Stein, MD, PhD, FAAD, Kelly C Nelson, MD, FAAD
5:10 PM
Q+A
DIRECTOR
Jennifer A. Stein, MD, PhD, FAAD
SPEAKERS
Konstantinos Liopyris, MD
Cristian Navarrete-Dechent, MD, IFAAD
Kelly C Nelson, MD, FAAD
Michelle B. Tarbox, MD, FAAD
Luc Thomas, MD, PhD
DISCLOSURES
Konstantinos Liopyris, MD
No financial relationships exist with ineligible companies.
Cristian Navarrete-Dechent, MD, IFAAD
No financial relationships exist with ineligible companies.
Kelly C Nelson, MD, FAAD
No financial relationships exist with ineligible companies.
Jennifer A. Stein, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Michelle B. Tarbox, MD, FAAD
Boehringer Ingelheim – Advisory Board(Honoraria); Castle Biosciences – Investigator(Grants/Research Funding); Dermaleve – Advisory Board(Honoraria); Galderma – Speaker(Honoraria); Novartis – Advisory Board(Honoraria); Sanofi/Regeneron – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Luc Thomas, MD, PhD
No financial relationships exist with ineligible companies.